BI 771716, Pegcetacoplan — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-28 in 3mo
ESTIMATED |
READOUT
A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-rela
Phase 2 · Macular Degeneration, Age-related, Geographic Atrophy |
Boehringer Ingelheim | BI 771716, Pegcetacoplan |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|